Prostate Cancer
News and reporting on prostate cancer.
Blue Earth Begins Radioligand Dosing in Phase II Prostate Cancer Trial
After establishing dosing and safety in Phase I, researchers will evaluate the drug's anti-tumor activity in patients with PSMA-expressing cancers.
In Cancer Resistance Battle, Drugmakers' Arsenal Contains Combo Drugs, Common Biomarkers, ctDNA
Premium
Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before first-generation therapies hit the market.
Telix Pharmaceuticals, Cardinal Health Partner to Distribute Prostate Cancer Imaging Agent in US
Cardinal is using its own cyclotron installations to produce Gozellix for distribution across a range of US locations.
Novigenix Wins €1.8M EU Grant to Work With Cancer Biomarker Consortium
The Swiss cancer liquid biopsy firm will contribute its expertise and technologies including its AI-driven LITOSeek liquid biopsy platform.
FDA Expands Pluvicto Indication to Earlier Line of Treatment for PSMA-Positive Prostate Cancer
Prostate cancer patients who have not yet received chemotherapy are now eligible for treatment with Pluvicto.